As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on economic growth, investors are keenly observing how these developments influence stock valuations. In this context, identifying undervalued stocks becomes crucial, as they may present opportunities for those looking to capitalize on potential market inefficiencies amid ongoing geopolitical and economic challenges.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| Teleste Oyj (HLSE:TLT1V) |
€3.61 |
€7.11 |
49.3% |
| Serviceware (XTRA:SJJ) |
€12.35 |
€24.58 |
49.8% |
| Revenio Group Oyj (HLSE:REG1V) |
€18.62 |
€36.77 |
49.4% |
| Recordati Industria Chimica e Farmaceutica (BIT:REC) |
€48.90 |
€95.82 |
49% |
| Nordisk Bergteknik (OM:NORB B) |
SEK11.35 |
SEK22.55 |
49.7% |
| Navamedic (OB:NAVA) |
NOK19.40 |
NOK38.65 |
49.8% |
| Exel Composites Oyj (HLSE:EXEL) |
€7.32 |
€14.47 |
49.4% |
| Dino Polska (WSE:DNP) |
PLN33.07 |
PLN65.65 |
49.6% |
| Careium (OM:CARE) |
SEK19.40 |
SEK38.05 |
49% |
| B&S Group (ENXTAM:BSGR) |
€5.85 |
€11.66 |
49.8% |
Below we spotlight a couple of our favorites from our exclusive screener.
Asmodee Group
Overview:Asmodee Group AB (publ) is involved in the publishing and distribution of tabletop games, with a market cap of approximately SEK24.38 billion.
Operations:The company generates revenue primarily from its Games & Toys segment, totaling €1.62 billion.
Estimated Discount To Fair Value:39.5%
Asmodee Group appears undervalued based on cash flows, trading at 39.5% below its estimated fair value of SEK172.57, with analysts forecasting a significant stock price increase of 51.9%. Despite a low forecasted return on equity of 8.6%, the company has become profitable and expects earnings growth of 36.6% annually, outpacing the Swedish market's growth rate. Recent strategic expansions into Japan and partnerships like Netflix adaptations could further bolster revenue streams without materially impacting current financial performance.
Vimian Group
Overview:Vimian Group AB (publ) operates in the global animal health sector and has a market cap of SEK14.61 billion.
Operations:The company's revenue segments are comprised of Medtech (€155.50 million), Diagnostics (€22.90 million), Specialty Pharma (€182.40 million), and Veterinary Services (€64.50 million).
Estimated Discount To Fair Value:21.3%
Vimian Group is trading at SEK27.6, below its estimated future cash flow value of SEK35.09, highlighting its undervaluation based on cash flows. The company forecasts a robust annual earnings growth of 28%, surpassing the Swedish market's 9.4%. However, while revenue is expected to grow at 8.7% annually—faster than the market—it remains slower than significant growth benchmarks and faces a forecasted low return on equity of 9.2%.
Verisure
Overview:Verisure plc offers security services for families and small businesses across Europe and Latin America, with a market cap of €9.04 billion.
Operations:The company's revenue segments include Portfolio Services at €3.27 billion, Customer Acquisition at €362.20 million, and Adjacencies at €115.40 million.
Estimated Discount To Fair Value:12.1%
Verisure is trading at €8.75, below its estimated future cash flow value of €9.95, indicating undervaluation based on cash flows. While revenue grew by 9.9% last year and is forecast to outpace the Swedish market at 8.4% annually, profitability remains a challenge with recent net losses and low return on equity forecasts of 9.2%. Analysts expect significant stock price appreciation, with a forecasted annual earnings growth of over 61%.
-
According our earnings growth report, there's an indication that Verisure might be ready to expand.
-
Click to explore a detailed breakdown of our findings in Verisure's balance sheet health report.
Where To Now?
-
Investigate our full lineup of 182 Undervalued European Stocks Based On Cash Flows right here.
-
Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
-
Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Searching for a Fresh Perspective?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:ASMDEE B OM:VIMIAN and OM:VSURE.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
